Clinical Trials Logo

Modeling Psychosis clinical trials

View clinical trials related to Modeling Psychosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT02492074 Not yet recruiting - Healthy Volunteers Clinical Trials

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study

Start date: December 2024
Phase: Phase 1
Study type: Interventional

The study evaluates the gene-environment interaction of the COMT-genotype on the effects of the phytocannabinoids delta-9-tetrahydrocannabinol, cannabidiol or a combination of both on induction of psychotic symptoms, endocannabinoid levels in human body fluids, neuronal processing, and neural oscillations. In addition the effects of the phytocannabinoids on lipid levels in serum and cerebrospinal fluid, cognition, neuronal processing assessed by fMRI as well as D2-receptor availability assessed by [18F] desmethoxyfallypride.

NCT ID: NCT02487381 Completed - Healthy Clinical Trials

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids

Start date: April 2015
Phase: Phase 1
Study type: Interventional

The study evaluates the gene-environment interaction of the COMT-genotype on the effects of the phytocannabinoids delta-9-tetrahydrocannabinol, cannabidiol or a combination of both on induction of psychotic symptoms, endocannabinoid levels in human body fluids, neuronal processing, and neural oscillations. In addition the effects of the phytocannabinoids on lipid levels in serum and cerebrospinal fluid, cognition, neural synchrony and neuronal processing assessed by EEG and fMRI.